The 39th Annual Conference: Clinical Hematology and Oncology 2019

Topics

• Changing approaches to hematologic malignancies, particularly as they relate to evidence-based standards of care, including innovations in diagnosis and treatment
• Clinical and molecular facets of pathogenesis, diagnostic approaches and therapeutic modalities available for various hematologic disorders
• Practical expertise gained from the clinical situations discussed in the workshop sessions with an emphasis on data-based approaches to patients with common but serious hematologic conditions
• New therapeutic options for the treatment of a number of common malignancies; understanding appropriate indications and contraindications to these therapeutic approaches
• Evolving approaches to various immunologic cancer treatments
• Evolving approaches to breast cancer from both a diagnostic, prognostic and therapeutic perspective

Who should Attend

Clinicians and leading experts in diverse areas of hematology and oncology.